ONKOCET Ltd. has exhibited the devices from its portfolio on the MEDTEC UK exhibition in Birmingham, April 2011 through our partner Medical & Partners.
As the result of the many year of experience with the quantum medical devices application the following advantages are revealed:
The possibility of reducing the dose of prescribed drugs and increase their therapeutic effect at the same time; a high immunoprophylactic potential; considerable shortening of in patient treatment, medical drug expenses and running patient costs; widening opportunities
For out patient treatment; absence of side effects, noninvasiveness and ecological safety; an increase in the organism ability to resist stress and deal with the environment; the possibility of mastering the technology within the shortest period of time (for medical staff 7 - 10 days).
There are also available safe medical prophylactic strategies, which can be recommended for independent domestic usage.
One of the Rikta's main peculiarities is the ability to influence the nerve, blood, endocrine, immune and respiratory system at the same time with several types of electromagnetic radiation:
* the pulsing infrared laser radiation;
* the pulsing broad band infrared radiation;
* the pulsing red radiation of the visible band;
* the fixed magnetic field.
The effect of the synergistic combination of the above brought about an increasing the therapeutic effects as compared to monotherapy (laser, magnetic, infrared, colour, electropulse therapy). Its application also improves the efficacy of any medicines taken and will allow very often a decrease in the dose of drugs.
These results have been confirmed in a multitude of reviews, patents, scientific and clinical studies:
1. The quantum medical devices Rikta® earlier produced with the trademark MILTA, VITYAZ are the unique Russian medical devices which received the international certificate of conformance to the quality standards of the European Union. They are approved and are commonly used either by the population for domestic usage or by medical staff in such countries as Germany, France, Switzerland, Spain, Israel and many others.
2. For efficiency and high therapeutic qualities the Rikta device was awarded with the Gold medal of the V international forum " High tech of XXI century"; the Gold Medal of Russian Academy of Natural Sciences" for the Practical benefits to the Consolidation of the Nation's Health"; the Gold Medal for " The Pioneer Achievements" at the XXIII International salon in
Geneva, 1995; The Certificate of the 3rd degree of the Academy of medical and technical sciences" for the Pioneer development"; the enterprise producing Rikta devices was the winner of All_Russian Competition: "1000 best Russian enterprises"; Prizewinner of following competitions:
" Best Moscow enterprise"; the winner of " The best enterprise of the District".
3. According to the special decision of the Committee of Sport and Health protection of the State Duma of the Russian Federation (Protocol ? 63 dated 24.01.02) the new technologies developed by the Quantum Medicine Association (including RIKTA® devices) was accepted as one of the best ways to improve domestic public health.
4. The RIKTA® device has major therapeutic benefits and has been used to treat thousands of people with a range of different diseases:
* cardiovascular;
* musculoskeletal system;
* urological;
* gynaecological;
* bronchopulmonary;
* gastrointestinal;
* otorhinolaryngology
* stomatological;
* ophthalmologic;
* skin;
* children;
* surgical;
* oncological.